Clinical trials
Follow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Maohaizi
- Development stage
- Unknown
- Lead developer
- Maohaizi Animal Health
- Modality
- Small Molecules
- Administration
- Oral, Topical
01
Overview
Maohaizi (毛孩子) is a brand of veterinary pharmaceutical products developed by Maohaizi Animal Health (Guangdong) Co., Ltd., a joint venture established by Joincare Pharmaceutical Group and Livzon Pharmaceutical Group. The brand encompasses a diverse portfolio of companion animal medications, including Miaoneining (喵内宁), the first domestic cat-specific gabapentin prescription tablet approved by China's Ministry of Agriculture and Rural Affairs for feline stress and anxiety management. Additionally, the portfolio features Likejian (丽可健), an imidacloprid and moxidectin spot-on solution, and Likeai (丽可爱), a milbemycin oxime and praziquantel tablet, which are widely used for the prevention and treatment of internal and external parasitic infections such as fleas, ear mites, heartworms, nematodes, and cestodes in dogs and cats.
- Brand names
- LikeaiLikejianMaohaiziMiaoneining
- Other names
- Mao HaiziMaohaizi Animal Health毛孩子毛孩子动保
02
Targets
GABAA (Gamma-aminobutyric acid receptor)GluCl (Glutamate-gated chloride channel)Nicotinic Acetylcholine ReceptorCACNA2D1 (Voltage-gated calcium channel subunit alpha2/delta-1)
Beyond the preview
Go deeper on Maohaizi.
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Indications & development
Explore development by indication, patient population, and geography.
- Indications
- Development status
- Countries
Licensing & deals
Trace asset ownership, licensing agreements, and commercial partnerships.
- Partners
- Deal terms
- Milestones
Patents & exclusivity
Explore the patent landscape and regulatory exclusivity around an asset.
- Patents
- Expiration dates
- Exclusivity
Competitive landscape
Compare development programs by target, modality, and indication.
- Competing assets
- Targets
- Development stage
Research & analysis
Connect source evidence and development news to your research questions.
- Publications
- News
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on Maohaizi.